These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Long-term remission of diabetes in NOD mice is induced by nondepleting anti-CD4 and anti-CD8 antibodies. Yi Z; Diz R; Martin AJ; Morillon YM; Kline DE; Li L; Wang B; Tisch R Diabetes; 2012 Nov; 61(11):2871-80. PubMed ID: 22751694 [TBL] [Abstract][Full Text] [Related]
23. Allorecognition and effector pathways of islet allograft rejection in normal versus nonobese diabetic mice. Makhlouf L; Yamada A; Ito T; Abdi R; Ansari MJ; Khuong CQ; Winn HJ; Auchincloss H; Sayegh MH J Am Soc Nephrol; 2003 Aug; 14(8):2168-75. PubMed ID: 12874472 [TBL] [Abstract][Full Text] [Related]
24. The role of CD4+ and CD8+ T cells in the destruction of islet grafts by spontaneously diabetic mice. Wang Y; Pontesilli O; Gill RG; La Rosa FG; Lafferty KJ Proc Natl Acad Sci U S A; 1991 Jan; 88(2):527-31. PubMed ID: 1899142 [TBL] [Abstract][Full Text] [Related]
26. Immunoregulatory effect of anti-thymocyte globulin monotherapy on peripheral lymphoid tissues of non-obese diabetic mice. Vargova L; Zacharovova K; Dovolilova E; Vojtova L; Saudek F Transplant Proc; 2011 Nov; 43(9):3277-80. PubMed ID: 22099776 [TBL] [Abstract][Full Text] [Related]
27. Lymphocyte subsets in thymus and peripheral lymphoid tissues of aging and diabetic NOD mice. Zhang ZL; Constantinou D; Mandel TE; Georgiou HM Autoimmunity; 1994; 17(1):41-8. PubMed ID: 8025213 [TBL] [Abstract][Full Text] [Related]
28. Effect of monoclonal anti-CD4 and anti-CD8 on skin allograft survival in mice treated with donor bone marrow cells. De Fazio SR; Masli S; Gozzo JJ Transplantation; 1996 Jan; 61(1):104-10. PubMed ID: 8560547 [TBL] [Abstract][Full Text] [Related]
29. Prevention of recurrent diabetes in syngenic islet-transplanted NOD mice by transfusion of autoreactive T lymphocytes. Utsugi T; Nagata M; Kawamura T; Yoon JW Transplantation; 1994 Jun; 57(12):1799-804. PubMed ID: 7912459 [TBL] [Abstract][Full Text] [Related]
30. Long-term islet graft survival in NOD mice by abrogation of recurrent autoimmunity. Shi Q; Wang D; Hadley GA; Bingaman AW; Bartlett ST; Farber DL Diabetes; 2004 Sep; 53(9):2338-45. PubMed ID: 15331543 [TBL] [Abstract][Full Text] [Related]
31. Combination therapy with epidermal growth factor and gastrin delays autoimmune diabetes recurrence in nonobese diabetic mice transplanted with syngeneic islets. Suarez-Pinzon WL; Rabinovitch A Transplant Proc; 2008 Mar; 40(2):529-32. PubMed ID: 18374121 [TBL] [Abstract][Full Text] [Related]
32. Anti-TCRβ mAb in Combination With Neurogenin3 Gene Therapy Reverses Established Overt Type 1 Diabetes in Female NOD Mice. Xie A; Li R; Jiang T; Yan H; Zhang H; Yang Y; Yang L; Yechoor V; Chan L; Chen W Endocrinology; 2017 Oct; 158(10):3140-3151. PubMed ID: 28977608 [TBL] [Abstract][Full Text] [Related]
33. Short administration of polyclonal anti-T cell antibody (ALS) in NOD mice with extensive insulitis prevents subsequent development of autoimmune diabetes. Ogawa N; Minamimura K; Kodaka T; Maki T J Autoimmun; 2006 Jun; 26(4):225-31. PubMed ID: 16713179 [TBL] [Abstract][Full Text] [Related]
34. Prevention of both rejection and recurrence of autoimmune disease in the NOD/Lt mouse following segmental pancreas transplantation. Purcell LJ; Mottram PL Transplant Proc; 1995 Jun; 27(3):2166-7. PubMed ID: 7792922 [TBL] [Abstract][Full Text] [Related]
35. Indefinite islet protection from autoimmune destruction in nonobese diabetic mice by agarose microencapsulation without immunosuppression. Kobayashi T; Aomatsu Y; Iwata H; Kin T; Kanehiro H; Hisanaga M; Ko S; Nagao M; Nakajima Y Transplantation; 2003 Mar; 75(5):619-25. PubMed ID: 12640299 [TBL] [Abstract][Full Text] [Related]
36. The effect of simultaneous CD154 and LFA-1 blockade on the survival of allogeneic islet grafts in nonobese diabetic mice. Berney T; Pileggi A; Molano RD; Poggioli R; Zahr E; Ricordi C; Inverardi L Transplantation; 2003 Dec; 76(12):1669-74. PubMed ID: 14688513 [TBL] [Abstract][Full Text] [Related]
37. Antibody combination therapy targeting CD25, CD70 and CD8 reduces islet inflammation and improves glycaemia in diabetic mice. Alkhamis T; Barbic J; Crnogorac-Jurcevic T; Greenlaw RE; Peakman M; Jurcevic S Clin Exp Immunol; 2012 Nov; 170(2):139-48. PubMed ID: 23039884 [TBL] [Abstract][Full Text] [Related]
38. TNF-alpha down-regulates type 1 cytokines and prolongs survival of syngeneic islet grafts in nonobese diabetic mice. Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Rajotte RV; Power RF J Immunol; 1997 Dec; 159(12):6298-303. PubMed ID: 9550435 [TBL] [Abstract][Full Text] [Related]
39. [The effects of NKG2D mAb on the survival of allogeneic transplanted islets in spontaneous diabetic nonobese diabetic mice]. Pan H; Lu YR; Zhang ZD; Jin X; Wei LL; Yuan Y; Lu HM; Mai G Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 41(5):836-9, 848. PubMed ID: 21302453 [TBL] [Abstract][Full Text] [Related]
40. "Indirect" acute islet allograft destruction in nonobese diabetic mice is independent of donor major histocompatibility complex and requires host B lymphocytes. Kupfer T; Beilke JN; Pham K; Buhrman J; Gill RG Transplant Proc; 2008 Mar; 40(2):462-3. PubMed ID: 18374102 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]